| Trial ID: | L0410 |
| Source ID: | NCT00312871
|
| Associated Drug: |
Epoetin Alfa
|
| Title: |
Effects of Early Correction of Anemia in Patients With Chronic Renal Insufficiency
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Anemia|Renal Failure, Chronic Renal Failure
|
| Interventions: |
DRUG: Epoetin alfa
|
| Outcome Measures: |
Primary: Rate of progression of chronic renal failure over 36 months as measured by at least 2 glomerular filtration rate assessments. | Secondary: Need for renal replacement therapy; quality of life; blood pressure control; hospital admissions; mortality; cardiovascular events; nutritional status.
|
| Sponsor/Collaborators: |
Sponsor: Janssen Cilag S.A.S.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
217
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2001-02
|
| Completion Date: |
2003-06
|
| Results First Posted: |
|
| Last Update Posted: |
2011-05-17
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00312871
|
